280 related articles for article (PubMed ID: 12922928)
1. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.
Appendino G; Harrison S; De Petrocellis L; Daddario N; Bianchi F; Schiano Moriello A; Trevisani M; Benvenuti F; Geppetti P; Di Marzo V
Br J Pharmacol; 2003 Aug; 139(8):1417-24. PubMed ID: 12922928
[TBL] [Abstract][Full Text] [Related]
2. Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin.
Rigoni M; Trevisani M; Gazzieri D; Nadaletto R; Tognetto M; Creminon C; Davis JB; Campi B; Amadesi S; Geppetti P; Harrison S
Br J Pharmacol; 2003 Mar; 138(5):977-85. PubMed ID: 12642400
[TBL] [Abstract][Full Text] [Related]
3. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia.
McDonald HA; Neelands TR; Kort M; Han P; Vos MH; Faltynek CR; Moreland RB; Puttfarcken PS
Eur J Pharmacol; 2008 Oct; 596(1-3):62-9. PubMed ID: 18755179
[TBL] [Abstract][Full Text] [Related]
4. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
[TBL] [Abstract][Full Text] [Related]
5. Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.
Szallasi A; Goso C; Blumberg PM; Manzini S
J Pharmacol Exp Ther; 1993 Nov; 267(2):728-33. PubMed ID: 8246148
[TBL] [Abstract][Full Text] [Related]
6. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
Seabrook GR; Sutton KG; Jarolimek W; Hollingworth GJ; Teague S; Webb J; Clark N; Boyce S; Kerby J; Ali Z; Chou M; Middleton R; Kaczorowski G; Jones AB
J Pharmacol Exp Ther; 2002 Dec; 303(3):1052-60. PubMed ID: 12438527
[TBL] [Abstract][Full Text] [Related]
7. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
[TBL] [Abstract][Full Text] [Related]
8. Capsazepine, a vanilloid receptor antagonist, inhibits allergen-induced tracheal contraction.
van den Worm E; de Vries A; Nijkamp FP; Engels F
Eur J Pharmacol; 2005 Jul; 518(1):77-8. PubMed ID: 15996655
[TBL] [Abstract][Full Text] [Related]
9. Cloning and pharmacological characterization of mouse TRPV1.
Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S
Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017
[TBL] [Abstract][Full Text] [Related]
10. Role of capsaicin-sensitive sensory nerves in protease-activated receptor-2-mediated contraction of rat urinary bladder.
Shimizu N; Nakahara T; Saito M; Ishii K
Eur J Pharmacol; 2007 Aug; 569(1-2):145-8. PubMed ID: 17588562
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man.
Szallasi A
Acta Physiol Scand Suppl; 1995; 629():1-68. PubMed ID: 8801775
[TBL] [Abstract][Full Text] [Related]
12. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1.
Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S
Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992
[TBL] [Abstract][Full Text] [Related]
14. Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man: a vote for BCTC.
Benko R; Illényi L; Kelemen D; Papp R; Papp A; Bartho L
Eur J Pharmacol; 2012 Jan; 674(1):44-50. PubMed ID: 22056835
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological investigation of hydrogen sulfide (H2S) contractile activity in rat detrusor muscle.
Patacchini R; Santicioli P; Giuliani S; Maggi CA
Eur J Pharmacol; 2005 Feb; 509(2-3):171-7. PubMed ID: 15733553
[TBL] [Abstract][Full Text] [Related]
16. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
[TBL] [Abstract][Full Text] [Related]
17. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
18. Relaxant effect of capsazepine in the isolated rat ileum.
Nocerino E; Izzo AA; Borrelli F; Capasso F; Capasso R; Pinto A; Sautebin L; Mascolo N
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):187-92. PubMed ID: 11882914
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by capsazepine of resiniferatoxin- and capsaicin-induced contractions of guinea pig trachea.
Ellis JL; Undem BJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):85-9. PubMed ID: 8301598
[TBL] [Abstract][Full Text] [Related]
20. TRPV1 is involved in stretch-evoked contractile changes in the rat autonomous bladder model: a study with piperine, a new TRPV1 agonist.
Gevaert T; Vandepitte J; Hutchings G; Vriens J; Nilius B; De Ridder D
Neurourol Urodyn; 2007; 26(3):440-50; discussion 451-3. PubMed ID: 17266134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
